Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report

Table 2 Reports on M. phlei infections

No. [Reference]	Age /Gender	Infected Organs	Background	Immuno- suppressive drug	Medication	Duration of therapy/ clinical outcome
1. [2]	7/M	synovial fluid and tissue	healthy	none	INH, RFP, and SM	9 month/cured
2. [3]	49/M	flexor digitorum longus and posterior tibialis tendon of his right foot.	healthy	none	CAM and CPFX	2 month/cured
3. [4]	17/M	peritonitis	CAPD due to FSGS	none	AMK, CFX and DOXY	9 month/cured
4. [5]	73/F	pacemaker infection	ICM(NYHAIII), DM, HT	none	DOXY	12 month/cured
5. [6]	N/A	lung	healthy	none	N/A	N/A
6. [6]	N/A	lung	healthy	none	N/A	N/A
7. [7]	N/A	lung	N/A	N/A	N/A	N/A
8. [8]	35/M	None (colonization)	AIDS CD4 455/μL	N/A	N/A	N/A
This case	79/F	Lung, lymph nodes, multiple bones	anti-IFN-γ autoantibodies	none	RFP, EB, CAM, and LVFX	26 month/cured

N/A not available, CAPD Continuous ambulatory peritoneal dialysis, FSGS focal and segmental glomerulosclerosis, ICM Ischemic cardiomyopathy, NYHA New York Heart Association, DM diabetes mellitus, HT hypertension, AIDS Acquired immune deficiency syndrome, INH Isoniazid, RFP Rifampin, SM Streptomycin, CAM Clarithromycin, CPFX Ciprofloxin, AMK Amikacin, CFX Cefoxitin, DOXY Doxycycline, EB Ethambutol, LVFX Levofloxacin

ISSN: 1471-2334